当前位置:首页 - 行情中心 - 益佰制药(600594) - 财务分析 - 现金流量表

益佰制药

(600594)

  

流通市值:29.06亿  总市值:29.06亿
流通股本:7.92亿   总股本:7.92亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金425,937,159.042,150,921,833.981,691,422,707.131,186,750,439.36
  收到的税费返还-3,189,148.111,051,843.961,051,843.96
  收到其他与经营活动有关的现金21,132,630.9290,845,196.7733,881,091.3329,329,226.74
  经营活动现金流入小计447,069,789.962,244,956,178.861,726,355,642.421,217,131,510.06
  购买商品、接受劳务支付的现金104,072,314.19445,324,871.82344,011,463.21239,552,154.95
  支付给职工以及为职工支付的现金130,301,113.35495,699,262.98381,217,750.61267,479,787.94
  支付的各项税费30,307,502.18165,541,054.17127,384,781.888,282,027.63
  支付其他与经营活动有关的现金137,210,796.87881,685,777.55669,943,421.46451,264,713.86
  经营活动现金流出小计401,891,726.591,988,250,966.521,522,557,417.081,046,578,684.38
  经营活动产生的现金流量净额45,178,063.37256,705,212.34203,798,225.34170,552,825.68
二、投资活动产生的现金流量:
  取得投资收益收到的现金113,934.5984,687.6636,878.89-
  处置固定资产、无形资产和其他长期资产收回的现金净额704,0006,903,944.2310,76022,486.8
  投资活动现金流入小计817,934.596,988,631.8947,638.8922,486.8
  购建固定资产、无形资产和其他长期资产支付的现金7,595,763.1334,992,693.7720,850,212.5713,770,190.21
  支付其他与投资活动有关的现金--2,164,525.67-
  投资活动现金流出小计7,595,763.1334,992,693.7723,014,738.2413,770,190.21
  投资活动产生的现金流量净额-6,777,828.54-28,004,061.88-22,967,099.35-13,747,703.41
三、筹资活动产生的现金流量:
  取得借款收到的现金255,000,000515,999,999.5427,999,999.5402,999,999.5
  筹资活动现金流入小计255,000,000515,999,999.5427,999,999.5402,999,999.5
  偿还债务支付的现金242,649,999.5754,797,667.66505,688,833.83363,260,000
  分配股利、利润或偿付利息支付的现金5,163,05828,686,363.3321,925,742.9314,856,616.07
  支付其他与筹资活动有关的现金2,814,903.835,082,856.288,523,223.287,543,503.8
  筹资活动现金流出小计250,627,961.3818,566,887.27536,137,800.04385,660,119.87
  筹资活动产生的现金流量净额4,372,038.7-302,566,887.77-108,137,800.5417,339,879.63
四、汇率变动对现金及现金等价物的影响-7,856.67-8,941.59-5,033.51-5,555.11
五、现金及现金等价物净增加额42,764,416.86-73,874,678.972,688,291.94174,139,446.79
  加:期初现金及现金等价物余额445,132,630.97519,007,309.87519,007,309.87519,007,309.87
  期末现金及现金等价物余额487,897,047.83445,132,630.97591,695,601.81693,146,756.66
补充资料:
  净利润--335,341,885.11--22,357,904.18
  资产减值准备-159,485,265.14-17,658,871.98
  固定资产和投资性房地产折旧-147,848,642.19-74,806,366.67
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-147,848,642.19-74,806,366.67
  无形资产摊销-16,079,766.47-8,087,814.12
  长期待摊费用摊销-21,890,040.99-11,225,552.98
  处置固定资产、无形资产和其他长期资产的损失-27,210,380.43--17,429.53
  固定资产报废损失-3,956,582.09-253,161.04
  财务费用-33,524,360.04-15,859,765.05
  投资损失-214,599.61-512,541.25
  递延所得税-9,726,350.78--9,500,590.5
  其中:递延所得税资产减少-12,528,536.1--8,240,227.33
    递延所得税负债增加--2,802,185.32--1,260,363.17
  存货的减少-76,677,456.55-20,622,506.6
  经营性应收项目的减少-145,721,217.84-109,333,174.15
  经营性应付项目的增加--60,456,463.39--60,766,093.23
  现金的期末余额-445,132,630.97-693,146,756.66
  减:现金的期初余额-519,007,309.87-519,007,309.87
  现金及现金等价物的净增加额--73,874,678.9-174,139,446.79
公告日期2026-04-232026-04-232025-10-302025-08-21
审计意见(境内)标准无保留意见
TOP↑